isocarboxazid has been researched along with Diabetes Mellitus in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geyer, G | 1 |
| Sokopp, B | 1 |
1 other study available for isocarboxazid and Diabetes Mellitus
| Article | Year |
|---|---|
Inhibition of lipolysis by methylisoxazole-carboxylic acid in maturity-onset diabetes.
Topics: Adipose Tissue; Blood Glucose; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucose Tolerance Test | 1973 |